Study On the Mechanism of Action of Qili Qiangxin Capsule in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking Method
Cardiovascular Reviews · 2024
DOI: 10.26689/cr.v2i2.7465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Reviews, 2024. Verfasst von Hao Sun und 4 weiteren Autor:innen.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Objective
To investigate the pharmacodynamic substances and mechanism of action of Qili Qiangxin Capsule in the treatment of heart failure based on network pharmacology and molecular docking technology.
Methods
The active ingredients and drug targets of Qili Qiangxin Capsule were obtained from databases such as TCMSP, GeneCards, OMIM, PharmGkb, TTD, and DrugBank databases were searched for heart failure disease targets. The drug targets and disease targets were corrected by the UniProt database, then the Venn diagram was drawn, and the intersecting genes were screened. Cytoscape 3.8.0 software was used to draw the active ingredient-disease target network for topological analysis. PPI network was constructed in the STRING database platform to predict the core targets. Bioconductor package was used to perform KEGG pathway analysis. autoDock Vina software was used to molecularly dock the core targets with the main active ingredients, and Pymol software visualised the results.
Results
Screening of 209 active ingredients of Qili Qiangxin Capsule, including quercetin, luteolin, cryptotanshinone, etc. 11,432 heart failure disease targets, 249 genes intersecting with drugs, including the core targets containing TP53, STAT3, JUN, MAPK1, etc. These genes are mainly involved in the AGE-RAGE, fluid shear stress, and atherosclerosis, PI3K-Akt signaling pathways.
Conclusion
This study initially revealed the multi-component, multi-target, multi-pathway mechanism of action of Qili Qiangxin Capsule in the treatment of heart failure, which provides a theoretical basis for further research.
Zitieren
APA
Sun, H., Ji, Y., Dong, H., Sun, Y., & Wang, P. (2024). Study On the Mechanism of Action of Qili Qiangxin Capsule in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking Method. Cardiovascular Reviews. https://doi.org/10.26689/cr.v2i2.7465
Vancouver
Sun H, Ji Y, Dong H, Sun Y, Wang P. Study On the Mechanism of Action of Qili Qiangxin Capsule in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking Method. Cardiovascular Reviews. 2024. doi:10.26689/cr.v2i2.7465
BibTeX
@article{Sun2024,
author = {Sun, Hao and Ji, Yongjian and Dong, Hongwei and Sun, Yi and Wang, Peng},
title = {Study On the Mechanism of Action of Qili Qiangxin Capsule in the Treatment of Heart Failure Based on Network Pharmacology and Molecular Docking Method},
journal = {Cardiovascular Reviews},
year = {2024},
doi = {10.26689/cr.v2i2.7465}
}
EUVIMED